Dr Neil Rabin is a consultant haematologist with a specialist interest in myeloma and plasma cell disorders at University College London Hospital (UCLH), as well as at the Royal Free / North Middlesex University Hospital.

Dr Rabin is responsible for the myeloma autologous stem cell programme at UCLH and is principal and co-investigator on several studies evaluating new treatments for myeloma, both at diagnosis and in relapse. 

He is past chair of the UK Myeloma Society and is a trustee at Myeloma UK.

Dr Dana Warcel is a Consultant Haematologist at Guy's and St Thomas' NHS Foundation Trust with a specialist interest in multiple myeloma and related plasma cell disorders. She graduated from Barts and The London with distinction in 2009 and completed specialist haematology training through the North Central London (UCLH) programme. Appointed as a substantive consultant in 2024, she manages tertiary referrals for plasma cell disorders and has presented at national and international conferences. She is a member of the UK Myeloma Research Alliance and is actively involved in clinical trials. She is the current lead for junior doctors in haematology, leads the Trust's bone marrow biopsy training programme, and has a strong interest in medical education, service development and improving patient care.

Dr Kevin Boyd has worked as a Consultant in the NHS for over a decade. On the clinical side he is Head of the Haematology Unit at the Royal Marsden Hospital, clinical lead for myeloma and is also involved in the regional diagnostics service. He has a PhD in myeloma genetics and has active research interests in clinical trials of novel therapies, myeloma imaging and diagnostics. He serves on the BSH Haem-onc task force and is involved in writing national guidelines, including the recent relapsed therapy guidelines for myeloma.